Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AbbVie Inc.

www.abbvie.com

Latest From Sirtris Pharmaceuticals Inc.

Navitor Pharmaceuticals Inc.

Navitor Pharmaceuticals Inc.’s drug discovery efforts are focused on producing compounds that can selectively dampen or bolster mTORC1 activity. Increased activity of mTORC1 has been linked to metabolic, autoimmune, neurodegenerative, and chronic inflammatory diseases.

BioPharmaceutical

From Public To Private, Crossover Investors Are Back In Biotech

Armed with cash from a robust M&A and a stock market boom, mutual and hedge funds are eagerly crossing over into mezzanine rounds for private biotechs and playing key roles in some of the year’s biggest venture financings.

BioPharmaceutical Business Strategies

From Public To Private, Crossover Investors Are Back In Biotech

Traditional life-science venture is shrinking, leaving gaps for others to fill. Crossover investors are now more creative and aggressive in reaching out to the best private companies. They often seek out entrepreneurs with glittering track records of repeat success, and some crossover investors also join mezzanine rounds to familiarize themselves with an interesting new company, management team, or technology earlier and at a lower cost than on the public markets.

BioPharmaceutical North America

Corporate Investors Boost M&A Step-Ups, But Not IPOs

Corporate venture capital groups have made an impact on life science investing in recent years, but when it comes to going public, the biotechs they back aren’t seeing an extra boost.

BioPharmaceutical Europe
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Gynecological, Urological
  • Immune Disorders
  • Infectious & Viral Diseases
  • Metabolic Disorders
  • Neurology, Nervous System
  • Renal System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Company Type
  • Big Pharma
  • Parent & Subsidiaries
  • AbbVie Inc.
  • Senior Management
  • Richard A Gonzalez, Chmn. & CEO
    William J Chase, EVP, CFO
    Michael Servino, MD, EVP, R&D & CSO
    Carlos Alban, EVP, Commercial Ops.
  • Contact Info
  • AbbVie Inc.
    Phone: (847) 937-6100
    1 N. Waukegan Rd.
    North Chicago, IL 60064
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register